de Macedo Filho Leonardo, Figueredo Luisa F, Villegas-Gomez Gustavo Adolfo, Arthur Matthew, Pedraza-Ciro Maria Camila, Martins Henrique, Kanawati Neto Joaquim, Hawryluk Gregory J, Amorim Robson Luís Oliveira
Neurosurgery Department, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033, USA.
Department of Psychiatry, NYU Langone Health, New York, NY 10016, USA.
Biomedicines. 2024 Feb 26;12(3):520. doi: 10.3390/biomedicines12030520.
Traumatic Brain Injury (TBI) remains a leading cause of morbidity and mortality among all ages; despite the advances, understanding pathophysiological responses after TBI is still complex, involving multiple mechanisms. Previous reviews have focused on potential targets; however, the research on potential targets has continuously grown in the last five years, bringing even more alternatives and elucidating previous mechanisms. Knowing the key and updated pathophysiology concepts is vital for adequate management and better outcomes. This article reviews the underlying molecular mechanisms, the latest updates, and future directions for pathophysiology-based TBI management.
创伤性脑损伤(TBI)仍然是各年龄段发病和死亡的主要原因;尽管取得了进展,但了解TBI后的病理生理反应仍然很复杂,涉及多种机制。以往的综述主要关注潜在靶点;然而,在过去五年中,对潜在靶点的研究不断增加,带来了更多的选择并阐明了先前的机制。了解关键的最新病理生理学概念对于进行充分的管理和取得更好的结果至关重要。本文综述了基于病理生理学的TBI管理的潜在分子机制、最新进展和未来方向。